Quick Answer
Compounded tirzepatide costs $299 to $549 per month in 2026 through US-licensed telehealth providers, depending on the provider, the dose, and the commitment tier, with the physician consultation, medication, and shipping typically bundled.
Compounded preparations are not FDA-approved as final products and are not generic versions of, equivalent to, or interchangeable with any brand-name medication. The active pharmaceutical ingredient meets United States Pharmacopeia (USP) standards. The pricing reflects production and program cost at accredited pharmacies, not lower quality.
2026 Compounded Tirzepatide Pricing (Real Numbers)
Pricing verified June 2026 against each provider's published pricing page. Re-verify quarterly; telehealth pricing changes often. How the telehealth path itself works is set out in how to get tirzepatide. All prices reflect cash pricing without insurance, in USD.
| Provider | Plan | First month | Ongoing | All-inclusive? |
|---|---|---|---|---|
| Majesta Health | Performance (tirzepatide injection) | $339 | $439/month | Yes (physician, medication, shipping, messaging) |
| Henry Meds | Compounded tirzepatide | $369 to $499/month | Same | Multiple commitment tiers |
| Medvi | Compounded tirzepatide injection | $329 | $429/month | Single plan structure |
| Mochi Health | Compounded tirzepatide + coaching | $79 membership + medication | Varies by dose | Membership plus medication structure |
2026 market shift you should know about. Hims & Hers and Ro, two of the largest telehealth names, both adjusted their compounded GLP-1 offerings in 2025-2026 and moved away from compounded tirzepatide. Ro now sells brand-name only. That leaves compounded tirzepatide to focused providers like Majesta Health, Henry Meds, Medvi, and Mochi. If you see an older article listing Hims or Ro compounded tirzepatide pricing, it is out of date.
For a broader walkthrough of buying compounded tirzepatide online, see our compounded tirzepatide online in 2026 guide.
If an FDA-Approved Product Is an Option for You
FDA-approved tirzepatide is a separate category with its own access routes, and it is worth checking before anything else. Ask your insurer whether an FDA-approved tirzepatide product is on your formulary and what prior authorization requires, and check the manufacturer's own patient programs for current self-pay pricing and eligibility. Those figures change, and the manufacturer is the only reliable source for them. If a listing offers what it calls a generic version of an approved tirzepatide product, why no approved generic is on the record explains what that description leaves out.
Whichever route is open to you, compare documented all-in monthly totals rather than headline prices.
For more on the medication itself, see our guide to compounded tirzepatide online in 2026.
What the Price Should Include
The headline price is only meaningful if you know what is bundled. A $199 plan that bills consultation, shipping, and refills separately can easily cost more than a $329 plan with everything included.
A legitimate $299 to $549 monthly compounded tirzepatide plan in 2026 should include:
- The compounded tirzepatide medication itself, prepared by a state-licensed compounding pharmacy
- Physician consultation with a US-licensed doctor (any medical consultation fee should be disclosed upfront)
- Discreet shipping in plain packaging
- Unlimited messaging or scheduled check-ins with your physician for dose adjustments and side-effect questions
- Ongoing dose adjustments through your titration phase
- The ability to cancel anytime without forfeiting a prepayment
What should NOT be hidden in the fine print:
- Separate consultation, lab, refill, or visit fees
- A required multi-month prepay to access the published price
- A required paid coaching tier bundled with the medication
- Dose-escalation upcharges (you should pay the same price across the titration range)
What Drives Compounded Pricing
Compounded tirzepatide contains an active pharmaceutical ingredient that meets United States Pharmacopeia (USP) standards. It is not FDA-approved as a final product and is not a generic version of, or interchangeable with, any brand product. Three things shape how compounded pricing is set:
- Ingredient and preparation. The active pharmaceutical ingredient, the concentration, and the vial size a pharmacy prepares all move the number.
- Batch size. State-licensed 503A pharmacies compound to individual prescriptions rather than running industrial manufacturing lines.
- What the plan includes. Some programs bundle the physician consultation, shipping, and follow-up messaging into the monthly figure and some bill them separately, which is the single biggest reason two quoted prices are hard to compare.
The trade-off is real and worth stating plainly: compounded preparations are not FDA-approved as final products. The active ingredient meets United States Pharmacopeia (USP) standards, and accredited pharmacies batch-test every preparation, but the specific compounded formulation has not been reviewed by the FDA the way the brand product has.
Insurance and HSA / FSA Reality (2026)
Commercial insurance almost never covers compounded tirzepatide. Coverage of the brand-name products is variable. Most weight-management-indication coverage requires prior authorization with documented BMI plus comorbidity criteria. Coverage for the diabetes indication is generally broader than coverage for weight management.
Medicare Part D covers the diabetes indication, and its statutory exclusion still bars a GLP-1 used solely for weight loss. Since July 1, 2026 a temporary federal program, the Medicare GLP-1 Bridge, covers certain brand products for chronic weight management at a $50 monthly copay for beneficiaries who qualify: see Medicare and GLP-1 coverage in 2026.
Medicaid varies by state. Many state programs cover these medications for diabetes only.
HSA and FSA cards typically reimburse prescription compounded tirzepatide when accompanied by valid documentation. Save your prescription confirmation and pharmacy receipts.
Dose and Price: How Titration Works
Tirzepatide dosing is not fixed. The prescribing clinician starts low and adjusts the dose over time based on your response and tolerability; the specific schedule belongs to your prescription label.
At a fair provider, the monthly price stays the same across that titration range. You should not pay more simply because your dose increased on schedule. If a provider's price climbs every time your dose goes up, that is a dose-escalation upcharge, and it can quietly turn a $299 headline into a much higher real cost at maintenance.
The Majesta Performance plan holds one price across the titration phase, so the number you see in month one is the number you plan around.
Hidden Fees to Watch For
The published headline is not the real cost if any of these are billed on the side:
- Separate consultation fees charged on top of the plan
- Shipping fees per order
- Refill or visit fees at each renewal
- Lab work fees required before the first fill
- Multi-month prepay required to unlock the lowest advertised price
- Cancellation penalties if you stop early
- Paid coaching tiers bundled in whether you want them or not
- Dose-escalation upcharges as your titration moves up
The honest way to compare two providers is to add up the total first-month cost including any one-time fees, then the total ongoing monthly cost with no commitment. Compare those two numbers, not the marketing headline.
How Majesta Performance Prices It
The Majesta Health Performance plan is compounded tirzepatide injection at a flat, all-in price:
- $339 your first month
- $439 per month after that
- One price held across the titration range (no dose-escalation upcharge)
- Includes the physician consultation, the compounded medication, discreet shipping, and ongoing physician messaging
Here is the all-in six-month math, which is the comparison that matters for cash-paying patients:
| Plan | Month 1 | Months 2-6 | Total six-month | Average / month |
|---|---|---|---|---|
| Majesta Performance (tirzepatide) | $339 | $439 × 5 = $2,195 | $2,534 | $422 |
| Other compounded providers (mid-tier $449/mo) | $449 | $449 × 5 = $2,245 | $2,694 | $449 |
Totals assume monthly billing; see each provider's billing policy for cycle details. This table compares compounded telehealth programs only; brand-name pricing is published by the manufacturers and depends on coverage.
Why Pricing Should Not Be the Only Factor
Three factors matter as much as price when evaluating any compounded tirzepatide source:
- Is the prescribing physician real and US-licensed? Cheap sources often skip this. Skipping medical screening is the actual safety risk.
- Is the dispensing pharmacy accredited? A state-licensed 503A pharmacy with NABP accreditation and LegitScript certification, that batch-tests every preparation for potency and sterility, operates at a much higher safety standard than an unaccredited one.
- Is ongoing physician access included? Side effects and dose adjustments happen for almost every patient in the first 2 to 3 months. Without a physician you can message, you handle them alone.
The pivotal tirzepatide trial programme studied the FDA-approved product; its results describe that product, not any compounded preparation. That is brand-product trial data, and individual results may vary. No legitimate provider, including Majesta, can promise a specific outcome for you.
The Bottom Line
In 2026, compounded tirzepatide costs $299 to $549 per month through US-licensed telehealth providers, all-in. Ask any provider for the documented monthly total in writing, including the consultation, the medication, and shipping, before you commit to anything.
Compounded preparations are not FDA-approved as final products; the active pharmaceutical ingredient meets United States Pharmacopeia (USP) standards.
The number that matters is not the headline. It is the all-in monthly cost at a provider with a real US-licensed physician, an accredited compounding pharmacy, one price across your titration range, and ongoing physician access included.
If you want a physician-reviewed recommendation specific to your situation, start your 2-minute medical assessment at /quiz. A US-licensed physician will review your information, screen for contraindications, and confirm the right plan for you.
Related guides
- Compounded tirzepatide online in 2026: the legitimate path
- Compounded semaglutide cost in 2026: the honest breakdown
This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider. Compounded medications are not FDA-approved as final products. Prices reflect typical 2026 US retail and are subject to change. Individual results may vary.
Frequently Asked Questions
How much does compounded tirzepatide cost per month in 2026?
Through US-licensed telehealth providers, compounded tirzepatide costs $299 to $549 per month in 2026, depending on the provider, the dose, and the commitment tier, with the physician consultation, medication, and shipping typically bundled. Brand-name prices and insurance coverage vary widely; current brand pricing is published by the manufacturers. Compounded preparations are not FDA-approved as final products and are not generic versions of, equivalent to, or interchangeable with any brand-name medication.
Why is compounded tirzepatide priced the way it is?
Compounded tirzepatide contains an active pharmaceutical ingredient that meets United States Pharmacopeia (USP) standards, prepared in small, patient-specific batches at state-licensed 503A compounding pharmacies. The monthly price reflects ingredient and preparation cost plus the bundled physician consultation and shipping, set by each provider. It is a separate category from FDA-approved brand medications, whose prices are set by the manufacturers and depend on coverage. The trade-off is that the compounded preparation itself is not FDA-approved as a final product and is not a generic version of, or interchangeable with, any brand product.
Does compounded tirzepatide cost more as the dose goes up?
At a legitimate provider, no. Tirzepatide titration starts low and moves up to a maintenance range on a schedule your prescribing clinician sets. A fair plan charges the same monthly price across that titration range. If a provider charges more each time your dose increases, that is a dose-escalation upcharge to watch for. The Majesta Performance plan holds one price across the titration phase.
Does insurance cover compounded tirzepatide?
Compounded tirzepatide is almost never covered by commercial insurance, Medicare, or Medicaid; it is a cash-pay program with one bundled monthly price. HSA and FSA cards are typically accepted by US-licensed telehealth providers with a valid prescription. If your insurance covers a brand-name product at a low copay, the covered brand route can win on math. Compare your documented out-of-pocket cost on any covered option against the all-in compounded cash price.
Can I use my HSA or FSA card for compounded tirzepatide?
In most cases, yes. HSA and FSA cards typically reimburse prescription compounded tirzepatide when accompanied by valid documentation. Save your prescription confirmation and pharmacy receipts in case your plan administrator asks for them. Most US-licensed telehealth providers accept HSA and FSA cards at checkout the same way they accept a regular debit or credit card.
What hidden fees should I watch for when comparing compounded tirzepatide prices?
Watch for separate consultation fees, shipping fees, refill fees, lab work fees, multi-month prepay requirements to access the published cheapest tier, plan cancellation penalties, paid coaching tiers bundled with the medication, and undisclosed dose-escalation upcharges. The fair way to compare providers is to compute the total first-month cost including any one-time fees, and the total ongoing monthly cost with no commitment.
Sources
This article is based on the following primary sources. Links open the original documents.
- 1.USP Compounding Standards (General Chapters 795, 797 and 800) · United States Pharmacopeia · accessed
- 2.Digital Pharmacy Accreditation · National Association of Boards of Pharmacy · accessed
- 3.Healthcare Merchant Certification · LegitScript · accessed
Is this available in your state?
Telehealth rules differ by state, and so does what a physician can prescribe remotely. Each state page covers the local telehealth requirements, whether a video visit is required, and the current status of our physician coverage there.
- California
- Texas
- Florida
- New York
- Pennsylvania
- Illinois
- Ohio
- Georgia
- North Carolina
- Michigan
- Arizona
- Washington
Majesta Health articles are written against primary sources (FDA labeling, NIH and CDC publications, state statutes) and each one passes a documented compliance review before publication. Where an article cites external sources, they are listed at the end of that article so you can check them yourself. No article currently carries an individual physician review; when a physician reviews an article, that page will show the reviewer's name, NPI and review date.
- Written against primary sources: FDA labeling and safety communications, NIH and CDC publications, state statutes and medical board rules
- Documented compliance review against FDA, FTC and LegitScript requirements before publication
- External sources, where an article cites them, are listed at the end of that article with links to the original documents
- Compounded medications are described as not FDA-approved as final products on every page that mentions them